Aclarion to showcase groundbreaking nociscan technology at the selby spine conference

Dr. sigurd berven to highlight nociscan capabilities, combining mr spectroscopy and augmented intelligence (ai)  nociscan as new gold standard in identifying a source of discogenic pain broomfield, colo., jan. 31, 2025 (globe newswire) -- aclarion, inc. (“aclarion” or the “company”) (nasdaq: acon, aconw), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (ai) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the selby spine conference.
ACON Ratings Summary
ACON Quant Ranking